Fresno physician Haifaa Abdulhaq made it clear what she wanted when she introduced herself during her first day on the governing board of a multibillion-dollar California state agency. “One of my ...

PASADENA, Calif., April 28, 2026 /PRNewswire/ -- AcuraStem, a biotechnology company advancing treatments for amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and other ...

Acurastem Inc. has been awarded $7.5 million in grant funding by the California Institute for Regenerative Medicine (CIRM) to support the advancement of lead clinical candidate AS-241 toward ...

The research initiative will investigate novel therapies to protect the aging brain from neurodegenerative diseases like Alzheimer's, Parkinson's and ALS. Fluorescent image of human neurons generated ...

It was a warm spring afternoon on the Sacramento River, not far from where gold was discovered in California more than 178 years ago. Directors of the state’s genetic research agency were meeting in a ...

The awards approved by the board support three clinical trial (CLIN2) grant applications with a combined approved total of $31M in financial support from CIRM. These grants fund clinical trials for ...

Last week, the California Institute for Regenerative Medicine (CIRM) approved a new funding program aimed at accelerating gene therapies for rare diseases by moving away from traditional approaches ...

NEW YORK – The California Institute for Regenerative Medicine (CIRM) has set aside $100 million to support a new program to fund platform approaches for rare disease treatments for the next two years.

The California Institute for Regenerative Medicine (CIRM) has awarded $7.4 million to support a University of California San Diego team developing a first-of-its-kind stem cell-based gene therapy for ...